Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Susan Tousi Biography and Net Worth

SVP of Illumina

Susan H. Tousi is the Chief Product Officer at Illumina Inc.

What is Susan H. Tousi's net worth?: The estimated net worth of Susan H. Tousi is at least $5.36 million as of August 22nd, 2023. Ms. Tousi owns 45,524 shares of Illumina stock worth more than $5,356,809 as of April 16th. This net worth evaluation does not reflect any other investments that Ms. Tousi may own. Learn More about Susan H. Tousi's net worth.
How do I contact Susan H. Tousi?: The corporate mailing address for Ms. Tousi and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected]. Learn More on Susan H. Tousi's contact information.
Has Susan H. Tousi been buying or selling shares of Illumina?: Susan H. Tousi has not been actively trading shares of Illumina during the last ninety days. Most recently, Susan H. Tousi sold 500 shares of the business's stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $167.04, for a transaction totalling $83,520.00. Following the completion of the sale, the senior vice president now directly owns 45,524 shares of the company's stock, valued at $7,604,328.96. Learn More on Susan H. Tousi's trading history.
Who are Illumina's active insiders?: Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.
Are insiders buying or selling shares of Illumina?: In the last year, Illumina insiders bought shares 1 times. They purchased a total of 7,330 shares worth more than $991,675.70. In the last year, insiders at the life sciences company sold shares 4 times. They sold a total of 1,815 shares worth more than $314,104.60. The most recent insider tranaction occured on February, 22nd when CEO Jacob Thaysen bought 7,330 shares worth more than $991,675.70. Insiders at Illumina own 0.2% of the company. Learn More about insider trades at Illumina.
Information on this page was last updated on 2/22/2024.

Susan H. Tousi Insider Trading History at Illumina

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/22/2023	Sell	500	$167.04	$83,520.00	45,524
7/24/2023	Sell	500	$190.08	$95,040.00	46,022
6/22/2023	Sell	500	$200.00	$100,000.00	46,522
2/6/2023	Sell	500	$211.57	$105,785.00	38,276
1/6/2023	Sell	500	$204.58	$102,290.00	38,662
12/6/2022	Sell	500	$212.63	$106,315.00	39,162
11/7/2022	Sell	500	$223.65	$111,825.00	40,112
10/6/2022	Sell	500	$216.59	$108,295.00	41,333
6/10/2022	Sell	250	$214.85	$53,712.50	41,833
1/12/2022	Sell	800	$425.00	$340,000.00
12/28/2021	Sell	100	$387.06	$38,706.00
12/8/2021	Sell	100	$375.00	$37,500.00
10/28/2021	Sell	100	$414.35	$41,435.00
9/28/2021	Sell	100	$418.04	$41,804.00
8/30/2021	Sell	300	$463.50	$139,050.00	41,456
8/4/2021	Sell	1,000	$500.00	$500,000.00
7/28/2021	Sell	300	$486.41	$145,923.00	42,743
6/28/2021	Sell	300	$478.95	$143,685.00
5/20/2021	Sell	500	$400.00	$200,000.00	43,343
5/5/2021	Sell	300	$381.88	$114,564.00	43,843
3/5/2021	Sell	800	$402.24	$321,792.00	44,943
1/20/2021	Sell	2,500	$400.00	$1,000,000.00	40,447
1/5/2021	Sell	300	$365.27	$109,581.00	42,947
12/7/2020	Sell	300	$349.34	$104,802.00	43,547
12/4/2020	Sell	200	$350.00	$70,000.00	43,547
10/12/2020	Sell	200	$350.00	$70,000.00	44,968
10/7/2020	Sell	100	$325.00	$32,500.00	45,168
9/8/2020	Sell	100	$336.00	$33,600.00	45,468
8/5/2020	Sell	800	$399.03	$319,224.00
7/20/2020	Sell	500	$400.00	$200,000.00	46,354
7/6/2020	Sell	300	$375.00	$112,500.00	46,854
5/28/2020	Sell	600	$375.00	$225,000.00	47,154
5/20/2020	Sell	300	$350.00	$105,000.00	47,754
5/12/2020	Sell	600	$325.00	$195,000.00	48,054
1/6/2020	Sell	200	$325.00	$65,000.00	38,465

Susan H. Tousi Buying and Selling Activity at Illumina

Illumina Company Overview

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Today's Range

Now: $117.69

$116.83

$119.56

50 Day Range

MA: $135.35

$121.16

$146.07

2 Week Range

Now: $117.69

$89.00

$232.23

Volume

1,696,982 shs

Average Volume

1,761,645 shs

Market Capitalization

$18.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad